logo-loader

Orgenesis explains the impacts of it's cell therapy development and manufacturing tech

Published: 16:26 05 Jun 2019 EDT

Orgenesis Inc.(NASDAQ:ORGS) CEO Vered Caplan meets Steve Darling of Proactive Investors at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA.

Lithium Australia and MinRes forge ahead with LieNA® pilot program

Lithium Australia Ltd (ASX:LIT, OTC:LMMFF) managing director Simon Linge discusses with Proactive’s Jonathan Jackson progress on its Mineral Resources Ltd (ASX:MIN) partnership having embarked on a pilot program for LieNA® processing technology. Linge elaborates on the joint development...

31 minutes ago